Aria Diagnostics, Inc., is a molecular diagnostics company committed to providing safe, highly accurate and affordable prenatal tests for maternal and fetal health. Led by an experienced team, Aria is using its proprietary technology to perform a directed analysis of cell-free DNA in blood. Aria's simple blood test equips pregnant women and their healthcare providers with reliable information to make decisions regarding their health, without creating unnecessary stress or anxiety.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 01/09/12 | $50,000,000 | Series C |
Domain Associates Meritech Capital Partners Venrock | undisclosed |
